GOSR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.5527136788005E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.40585329436271E-13 |
Normal-vs-Stage2 |
2.41917597065822E-13 |
Normal-vs-Stage3 |
3.87839760307429E-11 |
Normal-vs-Stage4 |
3.62043728330264E-12 |
Stage1-vs-Stage2 |
7.763400E-03 |
Stage1-vs-Stage3 |
1.224050E-01 |
Stage1-vs-Stage4 |
1.948170E-02 |
Stage2-vs-Stage3 |
3.943000E-01 |
Stage2-vs-Stage4 |
6.521200E-01 |
Stage3-vs-Stage4 |
6.865200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65945035490722E-12 |
Normal-vs-AfricanAmerican |
1.6894263765721E-12 |
Normal-vs-Asian |
3.369200E-01 |
Caucasian-vs-AfricanAmerican |
2.922100E-02 |
Caucasian-vs-Asian |
6.906000E-02 |
AfricanAmerican-vs-Asian |
5.844400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.33226762955019E-15 |
Normal-vs-Female |
6.33371133318406E-12 |
Male-vs-Female |
4.070200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.00299999919551E-08 |
Normal-vs-Age(41-60Yrs) |
2.93465252099168E-12 |
Normal-vs-Age(61-80Yrs) |
1.62614366416847E-12 |
Normal-vs-Age(81-100Yrs) |
4.83070000001362E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.998760E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.412400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.618400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.009600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.068200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.385100E-04 |
Normal-vs-Grade 2 |
4.56523707725864E-13 |
Normal-vs-Grade 3 |
8.43769498715119E-15 |
Normal-vs-Grade 4 |
1.89919968640595E-10 |
Grade 1-vs-Grade 2 |
7.927200E-01 |
Grade 1-vs-Grade 3 |
1.530970E-01 |
Grade 1-vs-Grade 4 |
5.684600E-01 |
Grade 2-vs-Grade 3 |
5.699800E-02 |
Grade 2-vs-Grade 4 |
4.992000E-01 |
Grade 3-vs-Grade 4 |
4.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.73638881051374E-12 |
Normal-vs-ccB subtype |
7.99329491485423E-11 |
ccA subtype-vs-ccB subtype |
5.510200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.82183215367149E-13 |
Normal-vs-N1 |
4.579100E-04 |
N0-vs-N1 |
8.908000E-01 |
|
|